RHYTHM PHARMACEUTICALS, INC. RYTM

Latest FY: 2025 Healthcare Biotechnology
Market Price $104.88
Market Cap $7.19B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑45.8% YoY
$189.76M
3-Yr CAGR: 100.2%
Net Income ↑24.6% YoY
-$196.54M
Net Margin: -103.6%
Free Cash Flow ↓-2.4% YoY
-$116.63M
FCF Yield: -1.62%
EPS (Diluted) ↑28.3% YoY
$-3.11
Basic: $-3.11
Return on Equity Efficiency
-141.3%
ROA: -40.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RYTM)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $-19.6M $-29.1M $-23.2M $-24.3M
FY 2017 $-22.9M $-37.6M -29.3% $-29.5M $-29.6M -21.9%
FY 2018 $-50.3M $-74.1M -97.1% $-62.1M $-62.8M -112.1%
FY 2019 $-109.5M $-140.7M -90.0% $-3.86 $-122.8M $-126.1M -100.9%
FY 2020 $-90.5M $-134.0M +4.8% $-3.04 +21.2% $-122.0M $-122.2M +3.1%
FY 2021 $3.2M $2.6M $-69.6M +48.0% $-1.40 +53.9% $-146.0M $-146.4M -19.8%
FY 2022 $23.6M +649.5% $18.4M $-181.1M -160.2% $-3.47 -147.9% $-173.4M $-173.7M -18.6%
FY 2023 $77.4M +227.6% $63.5M $-184.7M -2.0% $-3.20 +7.8% $-136.2M $-136.2M +21.6%
FY 2024 $130.1M +68.1% $109.5M $-260.6M -41.1% $-4.34 -35.6% $-113.9M $-113.9M +16.4%
FY 2025 $189.8M +45.8% $169.2M $-196.5M +24.6% $-3.11 +28.3% $-115.7M $-116.6M -2.4%
$

Valuation

Market Price $104.88
Market Cap $7.19B
Enterprise Value $7.25B
P/E Ratio N/A
P/B Ratio 51.73
FCF Yield -1.62%
Dividend Yield N/A
Shares Outstanding 68,593,600
%

Profitability & Margins

Gross Margin 89.15%
Operating Margin -101.19%
Net Margin -103.57%
Return on Equity (ROE) -141.32%
Return on Assets (ROA) -40.93%
Asset Turnover 0.40x
Revenue 3-Yr CAGR 100.23%
🛡️

Financial Health & Liquidity

Current Ratio 4.41
Cash Ratio 0.51
Debt / Equity 0.778
Debt / Assets 0.225
Cash & Equivalents $54.30M
Total Debt $108.18M
Book Value / Share $2.03
💧

Cash Flow Efficiency

Operating Cash Flow -$115.67M
Capital Expenditures (CapEx) $953.00K
Free Cash Flow -$116.63M
OCF / Revenue -60.96%
FCF / Revenue -61.46%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-3.11
EPS (Basic) $-3.11
Dividends / Share N/A
Book Value / Share $2.03
EPS YoY Growth 28.34%
🏛️

Balance Sheet (FY 2025)

Total Assets $480.20M
Total Liabilities $341.13M
Stockholders' Equity $139.07M
Current Assets $466.92M
Current Liabilities $105.94M